We are live on
!
Find out more
ADEF
Adams Diversified Equity Fund Portfolio holdings
AUM
$3.27B
1-Year Est. Return
45.57%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+45.57%
3 Year Est. Return
+150.13%
5 Year Est. Return
+214.77%
10 Year Est. Return
+830.6%
AUM
$2.02B
AUM Growth
+$138M
(+7.3%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
27.85%
Holding
243
New
32
Increased
16
Reduced
113
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$23.4M |
| 2 |
NVIDIA
NVDA
|
+$21.7M |
| 3 |
Mondelez International
MDLZ
|
+$19.8M |
| 4 |
US Bancorp
USB
|
+$18.5M |
| 5 |
Netflix
NFLX
|
+$18.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$24.6M |
| 2 |
Broadcom
AVGO
|
+$22.6M |
| 3 |
Philip Morris
PM
|
+$20M |
| 4 |
Labcorp
LH
|
+$19.3M |
| 5 |
Halliburton
HAL
|
+$16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.49% |
| 2 | Technology | 16.33% |
| 3 | Healthcare | 15.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRC
201
DELISTED
MRC Global
MRC
| $484K | 0.02% |
25,800
-1,900
| -7% | -$39.1K |
|
202
Cirrus Logic
CRUS
$6.74B
| $479K | 0.02% |
12,400
-800
| -6% | -$33.2K |
|
|
LCI
203
DELISTED
Lannett Company, Inc.
LCI
| $469K | 0.02% |
24,675
+17,625
| +250% | +$672K |
|
204
Phibro Animal Health
PAHC
$1.48B
| $438K | 0.02% |
10,200
-800
| -7% | -$37.8K |
|
205
Enanta Pharmaceuticals
ENTA
$387M
| $436K | 0.02% |
5,100
-300
| -6% | -$30.1K |
|
206
Amkor Technology
AMKR
$13.9B
| $430K | 0.02% |
58,200
-4,100
| -7% | -$34.8K |
|
|
TVRD
207
Tvardi Therapeutics
TVRD
$19M
| $410K | 0.02% |
+475
| New | +$343K |
|
|
AMAG
208
DELISTED
AMAG Pharmaceuticals
AMAG
| $370K | 0.02% |
18,500
-1,300
| -7% | -$29.6K |
|
209
MKS Inc
MKSI
$21.7B
| $345K | 0.02% |
4,300
-300
| -7% | -$27.4K |
|
210
Advanced Energy
AEIS
$13.7B
| $341K | 0.02% |
6,600
-500
| -7% | -$28.9K |
|
211
KLX Energy Services
KLXE
$43.3M
| $142K | 0.01% |
+888
| New | +$133K |
|
|
212
AbbVie
ABBV
$431B
| – | – |
-265,700
| Closed | -$24.6M |
|
213
AMN Healthcare
AMN
$1.29B
| – | – |
-15,500
| Closed | -$908K |
|
|
214
Broadcom
AVGO
$1.99T
| – | – |
-931,000
| Closed | -$22.6M |
|
215
Benchmark Electronics
BHE
$3.07B
| – | – |
-23,400
| Closed | -$682K |
|
216
Cathay General Bancorp
CATY
$4.3B
| – | – |
-19,300
| Closed | -$781K |
|
217
CytomX Therapeutics
CTMX
$723M
| – | – |
-17,800
| Closed | -$407K |
|
218
CVS Health
CVS
$133B
| – | – |
-174,800
| Closed | -$11.2M |
|
219
Delek US
DK
$4.06B
| – | – |
-13,000
| Closed | -$652K |
|
220
Deluxe
DLX
$1.24B
| – | – |
-8,800
| Closed | -$583K |
|
221
Editas Medicine
EDIT
$425M
| – | – |
-16,000
| Closed | -$573K |
|
222
Freeport-McMoran
FCX
$96.7B
| – | – |
-414,700
| Closed | -$7.16M |
|
|
223
Halliburton
HAL
$27B
| – | – |
-354,400
| Closed | -$16M |
|
|
224
Labcorp
LH
$25.3B
| – | – |
-125,363
| Closed | -$19.3M |
|
225
Lam Research
LRCX
$398B
| – | – |
-394,000
| Closed | -$6.81M |
|
Similar funds
BCI
MWM
PCM
FEG
AIP
SM
FNBOO
RPGK
Adams Diversified Equity Fund's Q3 2018 Portfolio in Review
As of Q3 2018, Adams Diversified Equity Fund held 243 positions worth $2.02B, up 7.3% from $1.88B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Adams Diversified Equity Fund's Q3 2018 filing shows 32 new, 16 increased, 113 reduced and 32 closed positions. Its largest new stake was Medtronic: 253,000 shares worth $24.9M. The largest sale was AbbVie, an estimated $24.6M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.
- Adams Diversified Equity Fund's largest Q3 2018 buy was Medtronic: 253,000 shares worth $24.9M.
- Adams Diversified Equity Fund added most to Netflix in Q3 2018, an estimated $18.4M increase.
- Adams Diversified Equity Fund's biggest Q3 2018 reduction was Philip Morris, cutting an estimated $20M.
- Adams Diversified Equity Fund fully exited AbbVie in Q3 2018, selling an estimated $24.6M.
- Adams Diversified Equity Fund's ten largest holdings make up 28% of its $2.02B portfolio in Q3 2018.
- Adams Diversified Equity Fund opened 32 new positions and closed 32 in Q3 2018.
- Adams Diversified Equity Fund's portfolio value rose 7.3% quarter-over-quarter to $2.02B.
Based on Adams Diversified Equity Fund's 13F filing for Q3 2018, filed 29 Oct 2018.